10
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T16161 | Mutant IDH1 inhibitor | Dehydrogenase , Isocitrate Dehydrogenase (IDH) | |
Mutant IDH1 inhibitor is an effective inhibitor of mutant IDH1 R132H (IC50: < 72 nM). | |||
T2043 | Mutant IDH1-IN-1 | IDH1-IN-1 | Dehydrogenase , Isocitrate Dehydrogenase (IDH) |
Mutant IDH1-IN-1 is a potent mutant IDH1 R132 h inhibitor with IC50 < 0.1 uM. | |||
T12128 | Mutant IDH1-IN-2 | Isocitrate Dehydrogenase (IDH) | |
Mutant IDH1-IN-2 is a mutant Isocitrate dehydrogenase (IDH) proteins inhibitor | |||
T11613 | IDH1 Inhibitor 1 | Others | |
IDH1 Inhibitor 1 is an orally bioavailable, brain-penetrant, and selective mutant IDH1 inhibitor (IC50s: 0.021 μM, 0.045 μM, and 2.52 μM for IDH1R132H, IDH1R132C, and IDH1WT). | |||
T11611 | IDH1 Inhibitor 2 | Dehydrogenase | |
IDH1 Inhibitor 2 (compound 13) is a potent IDH1 inhibitor via direct covalent modification of His315 (IC50: 110 nM). | |||
T11612 | IDH1 Inhibitor 3 | Others | |
IDH1 Inhibitor 3 is a mutant isocitric dehydrogenase 1 (IDH1) inhibitor (IC50: 45 nM for IDH1R132H). | |||
T7741 | DS-1001b | Dehydrogenase , Isocitrate Dehydrogenase (IDH) | |
DS-1001b is an inhibitor of mutant IDH-1 (Isocitrate Dehydrogenase-1) | |||
T7307 | Vorasidenib | PVM/MA,AG-881 | Isocitrate Dehydrogenase (IDH) |
Vorasidenib (PVM/MA) is an inhibitor of mutant isocitrate dehydrogenase (IDH; IC50s = 31.9 and 31.7 nM for IDH1R132H and IDH2R140Q, respectively) | |||
T16384 | Olutasidenib | FT-2102 | Dehydrogenase , Isocitrate Dehydrogenase (IDH) |
Olutasidenib (FT-2102) is under the study in the treatment of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Olutasidenib is a highly effective, brain penetrant, and selective inhibitor of the mutant Iso... | |||
T12129 | Mutant IDH1-IN-4 | Others | |
Mutant IDH1-IN-4 is an mutant Isocitrate dehydrogenase 1 (IDH 1) inhibitor. |